INHIBITION OF TUMOR-GROWTH IN A MOUSE FIBROSARCOMA AFTER INTERLEUKIN-2 APPLICATION

被引：3

作者：

BORBERG, H

ABDALLAH, A

SCHWULERA, U

SONNEBORN, H

机构：

[1] BIOTEST PHARMA GMBH,FRANKFURT,FED REP GER

[2] BIOTEST SERUM INST GMBH,DREIEICH,FED REP GER

来源：

关键词：

D O I：

10.1016/S0171-2985(86)80119-X

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：383 / 390

页数：8

共 11 条

[1] CANG AE, 1984, J BIOL RESPONSE MODI, V3, P561
[2] AUGMENTATION OF THE ANTI-TUMOR THERAPEUTIC EFFICACY OF LONG-TERM CULTURED LYMPHOCYTES-T BY INVIVO ADMINISTRATION OF PURIFIED INTERLEUKIN-2
CHEEVER, MA
GREENBERG, PD
FEFER, A
GILLIS, S
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (04) : 968 - 980
[3] CHEEVER MA, 1984, J IMMUNOL, V132, P2259
[4] STRUCTURES OF THE MAJOR CARBOHYDRATES OF NATURAL HUMAN INTERLEUKIN-2
CONRADT, HS
GEYER, R
HOPPE, J
GROTJAHN, L
PLESSING, A
MOHR, H
[J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1985, 153 (02): : 255 - 261
[5] CUNNINGHAMRUNDL.S, 1982, MODULATION NATURAL C, P415
[6] DONOHUE JH, 1983, J IMMUNOL, V130, P2203
[7] LONG-TERM CULTURE OF TUMOR-SPECIFIC CYTOTOXIC T-CELLS
GILLIS, S
SMITH, KA
[J]. NATURE, 1977, 268 (5616) : 154 - 156
[8] HEFENEIDER S, 1982, IN VIVO INTERLEUKIN, P421
[9] LOTZE MT, 1985, J IMMUNOL, V135, P2865
[10] OBSERVATIONS ON THE SYSTEMIC ADMINISTRATION OF AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2 TO PATIENTS WITH METASTATIC CANCER
ROSENBERG, SA
LOTZE, MT
MUUL, LM
LEITMAN, S
CHANG, AE
ETTINGHAUSEN, SE
MATORY, YL
SKIBBER, JM
SHILONI, E
VETTO, JT
SEIPP, CA
SIMPSON, C
REICHERT, CM
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (23) : 1485 - 1492